[Osteoporosis in pregnancy and lactation]
- PMID: 11436712
[Osteoporosis in pregnancy and lactation]
Abstract
Normal pregnancy and lactation lead to a combination of adaptive metabolic responses, the end result of which is to assure adequate delivery of mineral to the fetus while affording protection to the maternal skeleton. Elevated circulating levels of 1.25-OH vitamin D lead to increased efficiency of maternal intestinal calcium absorption and possibly lead to hypersecretion of calcitonin. Although serum concentrations of parathyroid hormone do not change during pregnancy, increased levels of a related hormone, PTH-related peptide, seem to contribute to a state of maternal functional hyperparathyroidism and maintain the fetal-maternal calcium gradient necessary to provide calcium to the fetus. Bone turnover increases during lactation and diminishes urinary calcium loss mobilizing mineral for the milk. Elevated levels of ionized calcium and phosphorus possibly correlate with increased bone resorption and decreased urinary excretion of these minerals. Bone mass is not normally lost during pregnancy but may decrease with sustained lactation for as long as six months. If lactation ceases before nine months, however, bone mass usually is restored. However, several rare forms of osteoporosis have been associated with pregnancy and lactation.
Similar articles
-
[Osteoporosis during pregnancy and lactation].Medicina (B Aires). 2005;65(6):533-40. Medicina (B Aires). 2005. PMID: 16433484 Review. Spanish.
-
Attainment of peak bone mass and bone turnover rate in relation to estrous cycle, pregnancy and lactation in colony-bred Sprague-Dawley rats: suitability for studies on pathophysiology of bone and therapeutic measures for its management.J Steroid Biochem Mol Biol. 2005 Apr;94(5):421-9. doi: 10.1016/j.jsbmb.2004.12.039. Epub 2005 Mar 28. J Steroid Biochem Mol Biol. 2005. PMID: 15876407
-
Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism.J Clin Endocrinol Metab. 1995 Dec;80(12):3699-707. doi: 10.1210/jcem.80.12.8530622. J Clin Endocrinol Metab. 1995. PMID: 8530622
-
[Osteoporosis during pregnancy and lactation. Report of eight cases].Medicina (B Aires). 2005;65(6):489-94. Medicina (B Aires). 2005. PMID: 16433474 Spanish.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
Analysis of Fracture Incidence in 135 Patients With Pregnancy and Lactation Osteoporosis (PLO).Cureus. 2021 Oct 24;13(10):e19011. doi: 10.7759/cureus.19011. eCollection 2021 Oct. Cureus. 2021. PMID: 34824928 Free PMC article.
-
Two cases of pregnancy- and lactation- associated osteoporosis successfully treated with denosumab.Clin Cases Miner Bone Metab. 2016 Sep-Dec;13(3):244-246. doi: 10.11138/ccmbm/2016.13.3.244. Epub 2017 Feb 10. Clin Cases Miner Bone Metab. 2016. PMID: 28228791 Free PMC article.
-
Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures.J Bone Miner Metab. 2012 Sep;30(5):596-601. doi: 10.1007/s00774-011-0334-0. Epub 2011 Nov 23. J Bone Miner Metab. 2012. PMID: 22105654